HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.

Abstract
Brain metabolism and the activity of the alpha-ketoglutarate dehydrogenase complex (KGDHC), a mitochondrial enzyme, are diminished in brains from patients with Alzheimer's disease (AD). In 109 subjects, the Clinical Dementia Rating (CDR) score was highly correlated with brain KGDHC activity. In AD patients who carried the epsilon 4 allele of the apolipoprotein E gene (ApoE4), the CDR score correlated better with KGDHC activity than with the densities of neuritic plaques or neuritic tangles. In contrast, in patients without ApoE4, the CDR score correlated significantly better with tangles and plaques than with KGDHC activity. The results suggest that mitochondrial/oxidative damage may be more important for the cognitive dysfunction in AD patients who carry ApoE4 than in those who do not.
AuthorsG E Gibson, V Haroutunian, H Zhang, L C Park, Q Shi, M Lesser, R C Mohs, R K Sheu, J P Blass
JournalAnnals of neurology (Ann Neurol) Vol. 48 Issue 3 Pg. 297-303 (Sep 2000) ISSN: 0364-5134 [Print] United States
PMID10976635 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Apolipoproteins E
Topics
  • Aged
  • Alzheimer Disease (genetics, pathology)
  • Analysis of Variance
  • Apolipoproteins E (genetics)
  • Brain (pathology)
  • Female
  • Genotype
  • Humans
  • Male
  • Mitochondria (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: